/Idexx%20Laboratories%2C%20Inc_%20outside%20lab-by%20Sundry%20Photography%20via%20iStock.jpg)
Valued at a market cap of $46.3 billion, IDEXX Laboratories, Inc. (IDXX) develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries. The Westbrook, Maine-based company is expected to announce its fiscal Q1 earnings for 2026 before the market opens on Tuesday, May 5.
Ahead of this event, analysts expect this healthcare company to report a profit of $3.42 per share, up 15.5% from $2.96 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. In Q4 2025, IDXX’s EPS of $3.08 outpaced the consensus expectations by 5.1%.